Journal article · 2024 · Open access
The evolution of Alzheimer’s disease therapies: A comprehensive review
Annals of Medical Science and Research, 3(1), 11–19 · Published 1 January 2024 · DOI 10.4103/amsr.amsr_37_23
In brief
“The evolution of Alzheimer’s disease therapies: A comprehensive review” is a 2024 journal article by Pritama Paul and 3 co-authors, published in Annals of Medical Science and Research. OpenAlex counts 1 citations as of 15 November 2026. It is open access under a CC BY-NC-SA licence: the full text is free to read at Annals of Medical Science and Research.
- Citations
- 1
- Most cited in
- 2024 (1)
- Field-weighted impact
- 0.13
- References
- 71
- Authors
- 4
Abstract
Alzheimer`s disease (AD) is a progressive neurodegenerative disease which accounts for most of the cases of dementia. The progression of the disease cannot be fully controlled by current medications, nor do they produce adequate therapeutic results. Understanding the molecular and cellular alterations linked to AD pathogenesis has advanced significantly in recent decades. Amyloid-peptide-containing cerebral plaques and thread-like neuronal structures made of the microtubule-associated protein TAU are two pathogenic features of the condition. Therefore, inhibiting amyloid formation, aggregation, or subsequent neurotoxic events is the primary goal of therapeutic drug development. Here, some newer therapeutic modalities are described, including anti-amyloid therapy, anti-tau therapy, antineuroinflammatory therapy, neuroprotective agents including N -methyl- d -aspartate (NMDA) receptor modulators, and brain stimulation. Drug repositioning may speed up the development of pharmaceuticals, but non-pharmacological therapies, particularly repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), also have the potential to be used in therapeutic settings. Here we discussed current symptomatic therapy for AD as well as novel prospective disease-modifying medicines that are presently being investigated in phase I–III trials in this review. The study emphasizes how taking into account the intricate nature of AD pathogenesis and investigating drug repurposing strategies which can open the door to the creation of innovative AD therapies.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Paul, P., Bhattacharjee, A., Bordoloi, S. K., & Paul, U. K. (2024). The evolution of Alzheimer’s disease therapies: A comprehensive review. Annals of Medical Science and Research, 3(1), 11–19. https://doi.org/10.4103/amsr.amsr_37_23
MLA 9
Paul, Pritama, et al. “The evolution of Alzheimer’s disease therapies: A comprehensive review.” Annals of Medical Science and Research, vol. 3, no. 1, 2024, pp. 11–19. https://doi.org/10.4103/amsr.amsr_37_23.
Chicago
Paul, Pritama, Abhishek Bhattacharjee, Susanta Kumar Bordoloi, and Uttam Kumar Paul. 2024. “The evolution of Alzheimer’s disease therapies: A comprehensive review.” Annals of Medical Science and Research 3 (1): 11–19. https://doi.org/10.4103/amsr.amsr_37_23.
Harvard
Paul, P. et al. (2024) ‘The evolution of Alzheimer’s disease therapies: A comprehensive review’, Annals of Medical Science and Research, 3(1), pp. 11–19. doi:10.4103/amsr.amsr_37_23.
IEEE
P. Paul, A. Bhattacharjee, S. K. Bordoloi, and U. K. Paul, “The evolution of Alzheimer’s disease therapies: A comprehensive review,” Annals of Medical Science and Research, vol. 3, no. 1, pp. 11–19, 2024, doi: 10.4103/amsr.amsr_37_23.
BibTeX
@article{paul2024evolution,
title = {{The evolution of Alzheimer’s disease therapies: A comprehensive review}},
author = {Paul, Pritama and Bhattacharjee, Abhishek and Bordoloi, Susanta Kumar and Paul, Uttam Kumar},
journal = {Annals of Medical Science and Research},
year = {2024},
volume = {3},
number = {1},
pages = {11--19},
doi = {10.4103/amsr.amsr_37_23},
url = {https://doi.org/10.4103/amsr.amsr_37_23}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Alzheimer's disease
- Alzheimer's disease treatment
- amyloid plaques
- tau pathology
- anti-amyloid therapy
- anti-tau therapy
- neuroinflammation
- neuroprotective agents
Work with this paper
Most-cited papers in Neuroscience
- The Rat Brain in Stereotaxic CoordinatesGeorge Paxinos, CHARLES R. R. WATSON · Elsevier eBooks · 1982 · 52,413 citations
- The assessment and analysis of handedness: The Edinburgh inventoryRichard Charles Oldfield · Neuropsychologia · 1971 · 36,725 citations
- EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysisArnaud Delorme A, Scott Makeig · Journal of Neuroscience Methods · 2004 · 25,302 citations
- The Ecological Approach to Visual PerceptionMarc H. Bornstein, James J. Gibson · Journal of Aesthetics and Art Criticism · 1980 · 22,977 citations
- The Psychophysics ToolboxDavid H. Brainard · Spatial Vision · 1997 · 20,208 citations
Questions about this paper
How do I cite this paper in APA style?
Paul, P., Bhattacharjee, A., Bordoloi, S. K., & Paul, U. K. (2024). The evolution of Alzheimer’s disease therapies: A comprehensive review. Annals of Medical Science and Research, 3(1), 11–19. https://doi.org/10.4103/amsr.amsr_37_23
How many times has this paper been cited?
1 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Annals of Medical Science and Research.
Who wrote this paper?
Pritama Paul, Abhishek Bhattacharjee, Susanta Kumar Bordoloi, Uttam Kumar Paul.
What is the DOI of this paper?
10.4103/amsr.amsr_37_23. The permanent link is https://doi.org/10.4103/amsr.amsr_37_23.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.